These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30949886)

  • 1. N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m
    Nitta K; Nagai T; Mizunuma Y; Kitada M; Nakagawa A; Sakurai M; Toyoda M; Haneda M; Kanasaki K; Koya D
    Clin Exp Nephrol; 2019 Aug; 23(8):1004-1012. PubMed ID: 30949886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.
    Nitta K; Shi S; Nagai T; Kanasaki M; Kitada M; Srivastava SP; Haneda M; Kanasaki K; Koya D
    Biomed Res Int; 2016; 2016():9172157. PubMed ID: 27088094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
    Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
    J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Betz BB; Jenks SJ; Cronshaw AD; Lamont DJ; Cairns C; Manning JR; Goddard J; Webb DJ; Mullins JJ; Hughes J; McLachlan S; Strachan MWJ; Price JF; Conway BR
    Kidney Int; 2016 May; 89(5):1125-1135. PubMed ID: 27083286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.
    Bhensdadia NM; Hunt KJ; Lopes-Virella MF; Michael Tucker J; Mataria MR; Alge JL; Neely BA; Janech MG; Arthur JM;
    Kidney Int; 2013 Jun; 83(6):1136-43. PubMed ID: 23536133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans.
    Azizi M; Ezan E; Reny JL; Wdzieczak-Bakala J; Gerineau V; Ménard J
    Hypertension; 1999 Mar; 33(3):879-86. PubMed ID: 10082503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes.
    Colombo M; McGurnaghan SJ; Blackbourn LAK; Dalton RN; Dunger D; Bell S; Petrie JR; Green F; MacRury S; McKnight JA; Chalmers J; Collier A; McKeigue PM; Colhoun HM;
    Diabetologia; 2020 Apr; 63(4):788-798. PubMed ID: 31915892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Plasma N-acetyl-seryl-aspartyl-lysyl-proline Level in Stable Kidney Transplant Recipients.
    Suzuki Y; Katagiri F; Sato F; Fujioka K; Sato Y; Fujioka T; Sato Y; Mimata H; Itoh H
    Clin Lab; 2016 Jul; 62(7):1323-1328. PubMed ID: 28164637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?
    El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA
    Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
    J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary NGAL and RBP Are Biomarkers of Normoalbuminuric Renal Insufficiency in Type 2 Diabetes Mellitus.
    Li A; Yi B; Liu Y; Wang J; Dai Q; Huang Y; Li YC; Zhang H
    J Immunol Res; 2019; 2019():5063089. PubMed ID: 31637265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease.
    Gohda T; Kamei N; Koshida T; Kubota M; Tanaka K; Yamashita Y; Adachi E; Ichikawa S; Murakoshi M; Ueda S; Suzuki Y
    J Diabetes Investig; 2020 Mar; 11(2):435-440. PubMed ID: 31483944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.